T Cell News and Research

Latest T Cell News and Research

M. D. Anderson wins $8.3-million to research environmental causes of major diseases

An $8.3-million federal grant to The University of Texas M. D. Anderson Cancer Center Science Park - Research Division addresses the complex interplay between such varied factors as genetics, diet, and environmental exposure to toxins that cause cancer, asthma, diabetes, cardiovascular and other diseases.

21 Apr 2007

Knocking out Mcl1 protein could aid leukemia treatment

An effective way to fight leukemia might be to knock out a specific protein that protects cancer cells from dying, a new study shows.

21 Apr 2007

Discovery of molecular mechanism that alters strength of higher brain network connections

Yale School of Medicine and University of Crete School of Medicine researchers report in Cell April 20 the first evidence of a molecular mechanism that dynamically alters the strength of higher brain network connections.

21 Apr 2007

Why cisplatin kills breast cancer cells when other drugs fail

The cancerous cells of some individuals with breast cancer lack expression of two cell surface proteins, the estrogen and progesterone receptors, and do not express increased amounts of HER2.

20 Apr 2007

Protein called CREB key to memory storage in brain

Scientists know little about how the brain assigns cells to participate in encoding and storing memories.

20 Apr 2007

Schering-Plough plans phase III trials for novel selective antiplatelet therapy

Schering-Plough Corporation has announced plans to initiate two global Phase III large-scale clinical outcomes trials for its novel selective oral antiplatelet therapy, the thrombin receptor antagonist (TRA) SCH 530348.

20 Apr 2007

Novel targeted therapy effectively treats acute leukemia

Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.

20 Apr 2007

New research may help identify patients most likely to benefit from cisplatin treatment

Researchers at the Massachusetts General Hospital (MGH) Cancer Center have identified a subgroup of hard-to-treat breast cancers that may be sensitive to the drug cisplatin, rarely used in the treatment of breast tumors.

20 Apr 2007

Green tea may help protect against Sjogren's syndrome

They found significantly less salivary gland damage in a group treated with green tea extract, suggesting a reduction of the Sjogren's symptom commonly referred to as dry mouth. Dry mouth can also be caused by certain drugs, radiation and other diseases.

20 Apr 2007

Natural ingredient in human blood found to block HIV-1

A new study has pinpointed a natural ingredient of human blood that effectively blocks HIV-1, the virus predominantly responsible for human AIDS, from infecting immune cells and multiplying.

20 Apr 2007

Novel forms of synaptic plasticity uncovered

The Chicago Medical School (CMS) of the Rosalind Franklin University of Medicine and Science (RFUMS) have announced that Assistant Professor of Cell Biology and Anatomy, Athanasios Tzounopoulos, has uncovered novel forms of synaptic plasticity that occur at the very first step in the processing of sound in the central nervous system. His findings are released in Neuron.

20 Apr 2007

Viventia Biotech announces results of Proxinium antibody in combinaton with chemotherapy and radiation

Viventia Biotech has announced results of in vitro cytotoxicity and in vivo pharmacokinetic studies conducted to evaluate the potential for combining its phase III anti-cancer antibody therapeutic, Proxinium, with first-line standard of care therapy for squamous cell carcinoma of the head & neck (SCCHN).

19 Apr 2007

Scent prediction test

The scent of lily of the valley hangs in the air for readers of the journal Angewandte Chemie: just rub the journal's cover and enjoy a lily-of-the-valley scent.

19 Apr 2007

Researchers identify key gene that may be a marker of breast cancer metastasis

Despite the fact that they both infect the liver, the hepatitis A and hepatitis C viruses actually have very little in common.

19 Apr 2007

Researchers find hepatitis A and hepatitis C attack same protein to block immune defenses

Despite the fact that they both infect the liver, the hepatitis A and hepatitis C viruses actually have very little in common.

19 Apr 2007

Protalix BioTherapeutics receives FDA approval to initiate a phase III trial of prGCD

Protalix BioTherapeutics, Inc. has announced that it has received written notice from the United States Food and Drug Administration (FDA) that it may initiate a Phase III clinical trial in the United States of its lead product candidate, prGCD, a proprietary plant cell expressed recombinant form of human Glucocerebrosidase (GCD), for the treatment of Gaucher Disease, a lysosomal storage disorder in humans.

19 Apr 2007

New approach to cystic fibrosis treatment

Researchers at the University of Pennsylvania School of Medicine have discovered that an enzyme produced by lung-infecting bacteria further shuts down a protein that is defective in cystic fibrosis patients.

19 Apr 2007

Novel method to expand the number of immune system "natural killer" cells from blood cells outside the body

Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia have devised a novel method to expand the number of immune system "natural killer (NK)" cells from blood cells outside the body.

19 Apr 2007

Jefferson participates in global study to extend effectiveness of drug for Parkinson's

After Parkinson's disease patients use the drug levodopa or L-dopa for several years as a treatment for restoring the cellular communication that controls muscle movement by replacing lost dopamine, they begin to experience motor complications that include a shortened response to each dose of L-dopa.

19 Apr 2007

Neurobiologists pinpoint how brain copes with shifty eyeballs

Neurobiologists have pinpointed brain regions critical to one of the brain's more remarkable feats'piecing together a continuous view of the world by integrating snippets of visual input from constantly moving eyes.

19 Apr 2007

T Cell News and Research

Latest T Cell News and Research

M. D. Anderson wins $8.3-million to research environmental causes of major diseases

Knocking out Mcl1 protein could aid leukemia treatment

Discovery of molecular mechanism that alters strength of higher brain network connections

Why cisplatin kills breast cancer cells when other drugs fail

Protein called CREB key to memory storage in brain

Schering-Plough plans phase III trials for novel selective antiplatelet therapy

Novel targeted therapy effectively treats acute leukemia

New research may help identify patients most likely to benefit from cisplatin treatment

Green tea may help protect against Sjogren's syndrome

Natural ingredient in human blood found to block HIV-1

Novel forms of synaptic plasticity uncovered

Viventia Biotech announces results of Proxinium antibody in combinaton with chemotherapy and radiation

Scent prediction test

Researchers identify key gene that may be a marker of breast cancer metastasis

Researchers find hepatitis A and hepatitis C attack same protein to block immune defenses

Protalix BioTherapeutics receives FDA approval to initiate a phase III trial of prGCD

New approach to cystic fibrosis treatment

Novel method to expand the number of immune system "natural killer" cells from blood cells outside the body

Jefferson participates in global study to extend effectiveness of drug for Parkinson's

Neurobiologists pinpoint how brain copes with shifty eyeballs

Immunology eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in